A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery

NCT00902928 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

1992

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism
Arthroplasty, Replacement, Hip

Interventions

DRUG: YM150
DRUG: enoxaparin

Sponsor

Astellas Pharma Europe B.V.